NCT00781170View on ClinicalTrials.gov

Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2000

Conditions

Multiple MyelomaStem Cell Transplantation

Interventions

PROCEDURE

allogeneic hematopoietic SCT

All Listed Sponsors

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT00781170 - Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter